检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

497-Lebrikizumab in combination with topical corticosteroids maintains improvements in itch and sleep at 68 weeks in patients with moderate-to-severe atopic dermatitis

Gil Yosipovitch,Peter A. Lio,David Rosmarin,Marta Casillas,Fan Emily Yang, Chaoran Hu,Evangeline Pierce,Franz J. Legat, Jose-Manuel Carrascosa,Heidi Crane, Laia Boncompte,Sonja Stander

BRITISH JOURNAL OF DERMATOLOGY（2024）

引用 0|浏览0
暂无评分
关键词
moderate-to-severe atopic dermatitis,itch,sleep loss due to itch,lebrikizumab,long term
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要